Hemangioma Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: HD8082FB6584EN
Market Monitor Global

Abstracts

Hemangioma is the birthmark or benign tumors of infancy that occurs due to an abnormal collection of blood vessels. This occurs in 5-10% of infants worldwide.

This report contains market size and forecasts of Hemangioma in Global, including the following market information:

Global Hemangioma Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hemangioma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medical Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemangioma include Akrimax, AstraZeneca, Novartis, Cutting Edge Laser Technologies, Pfizer and Pierre Fabre, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemangioma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemangioma Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hemangioma Market Segment Percentages, by Type, 2021 (%)

• Medical Therapy
• Laser Therapy
• Surgery
• Other

Global Hemangioma Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hemangioma Market Segment Percentages, by Application, 2021 (%)

• Adult
• Child

Global Hemangioma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hemangioma Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemangioma revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hemangioma revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Akrimax
• AstraZeneca
• Novartis
• Cutting Edge Laser Technologies
• Pfizer
• Pierre Fabre

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemangioma Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemangioma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMANGIOMA OVERALL MARKET SIZE

2.1 Global Hemangioma Market Size: 2021 VS 2028
2.2 Global Hemangioma Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemangioma Players in Global Market
3.2 Top Global Hemangioma Companies Ranked by Revenue
3.3 Global Hemangioma Revenue by Companies
3.4 Top 3 and Top 5 Hemangioma Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemangioma Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemangioma Players in Global Market
  3.6.1 List of Global Tier 1 Hemangioma Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemangioma Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hemangioma Market Size Markets, 2021 & 2028
  4.1.2 Medical Therapy
  4.1.3 Laser Therapy
  4.1.4 Surgery
  4.1.5 Other
4.2 By Type - Global Hemangioma Revenue & Forecasts
  4.2.1 By Type - Global Hemangioma Revenue, 2017-2022
  4.2.2 By Type - Global Hemangioma Revenue, 2023-2028
  4.2.3 By Type - Global Hemangioma Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemangioma Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Child
5.2 By Application - Global Hemangioma Revenue & Forecasts
  5.2.1 By Application - Global Hemangioma Revenue, 2017-2022
  5.2.2 By Application - Global Hemangioma Revenue, 2023-2028
  5.2.3 By Application - Global Hemangioma Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hemangioma Market Size, 2021 & 2028
6.2 By Region - Global Hemangioma Revenue & Forecasts
  6.2.1 By Region - Global Hemangioma Revenue, 2017-2022
  6.2.2 By Region - Global Hemangioma Revenue, 2023-2028
  6.2.3 By Region - Global Hemangioma Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hemangioma Revenue, 2017-2028
  6.3.2 US Hemangioma Market Size, 2017-2028
  6.3.3 Canada Hemangioma Market Size, 2017-2028
  6.3.4 Mexico Hemangioma Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hemangioma Revenue, 2017-2028
  6.4.2 Germany Hemangioma Market Size, 2017-2028
  6.4.3 France Hemangioma Market Size, 2017-2028
  6.4.4 U.K. Hemangioma Market Size, 2017-2028
  6.4.5 Italy Hemangioma Market Size, 2017-2028
  6.4.6 Russia Hemangioma Market Size, 2017-2028
  6.4.7 Nordic Countries Hemangioma Market Size, 2017-2028
  6.4.8 Benelux Hemangioma Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hemangioma Revenue, 2017-2028
  6.5.2 China Hemangioma Market Size, 2017-2028
  6.5.3 Japan Hemangioma Market Size, 2017-2028
  6.5.4 South Korea Hemangioma Market Size, 2017-2028
  6.5.5 Southeast Asia Hemangioma Market Size, 2017-2028
  6.5.6 India Hemangioma Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hemangioma Revenue, 2017-2028
  6.6.2 Brazil Hemangioma Market Size, 2017-2028
  6.6.3 Argentina Hemangioma Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemangioma Revenue, 2017-2028
  6.7.2 Turkey Hemangioma Market Size, 2017-2028
  6.7.3 Israel Hemangioma Market Size, 2017-2028
  6.7.4 Saudi Arabia Hemangioma Market Size, 2017-2028
  6.7.5 UAE Hemangioma Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Akrimax
  7.1.1 Akrimax Corporate Summary
  7.1.2 Akrimax Business Overview
  7.1.3 Akrimax Hemangioma Major Product Offerings
  7.1.4 Akrimax Hemangioma Revenue in Global Market (2017-2022)
  7.1.5 Akrimax Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Hemangioma Major Product Offerings
  7.2.4 AstraZeneca Hemangioma Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Hemangioma Major Product Offerings
  7.3.4 Novartis Hemangioma Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Cutting Edge Laser Technologies
  7.4.1 Cutting Edge Laser Technologies Corporate Summary
  7.4.2 Cutting Edge Laser Technologies Business Overview
  7.4.3 Cutting Edge Laser Technologies Hemangioma Major Product Offerings
  7.4.4 Cutting Edge Laser Technologies Hemangioma Revenue in Global Market (2017-2022)
  7.4.5 Cutting Edge Laser Technologies Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Hemangioma Major Product Offerings
  7.5.4 Pfizer Hemangioma Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Pierre Fabre
  7.6.1 Pierre Fabre Corporate Summary
  7.6.2 Pierre Fabre Business Overview
  7.6.3 Pierre Fabre Hemangioma Major Product Offerings
  7.6.4 Pierre Fabre Hemangioma Revenue in Global Market (2017-2022)
  7.6.5 Pierre Fabre Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemangioma Market Opportunities & Trends in Global Market
Table 2. Hemangioma Market Drivers in Global Market
Table 3. Hemangioma Market Restraints in Global Market
Table 4. Key Players of Hemangioma in Global Market
Table 5. Top Hemangioma Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemangioma Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemangioma Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemangioma Product Type
Table 9. List of Global Tier 1 Hemangioma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemangioma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hemangioma Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemangioma Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemangioma Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hemangioma Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemangioma Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemangioma Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hemangioma Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemangioma Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemangioma Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemangioma Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemangioma Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemangioma Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemangioma Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemangioma Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemangioma Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemangioma Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemangioma Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemangioma Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemangioma Revenue, (US$, Mn), 2023-2028
Table 30. Akrimax Corporate Summary
Table 31. Akrimax Hemangioma Product Offerings
Table 32. Akrimax Hemangioma Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Hemangioma Product Offerings
Table 35. AstraZeneca Hemangioma Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Hemangioma Product Offerings
Table 38. Novartis Hemangioma Revenue (US$, Mn), (2017-2022)
Table 39. Cutting Edge Laser Technologies Corporate Summary
Table 40. Cutting Edge Laser Technologies Hemangioma Product Offerings
Table 41. Cutting Edge Laser Technologies Hemangioma Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Hemangioma Product Offerings
Table 44. Pfizer Hemangioma Revenue (US$, Mn), (2017-2022)
Table 45. Pierre Fabre Corporate Summary
Table 46. Pierre Fabre Hemangioma Product Offerings
Table 47. Pierre Fabre Hemangioma Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hemangioma Segment by Type in 2021
Figure 2. Hemangioma Segment by Application in 2021
Figure 3. Global Hemangioma Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemangioma Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemangioma Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemangioma Revenue in 2021
Figure 8. By Type - Global Hemangioma Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemangioma Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemangioma Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemangioma Revenue Market Share, 2017-2028
Figure 12. US Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemangioma Revenue Market Share, 2017-2028
Figure 16. Germany Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemangioma Revenue Market Share, 2017-2028
Figure 24. China Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemangioma Revenue Market Share, 2017-2028
Figure 30. Brazil Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemangioma Revenue Market Share, 2017-2028
Figure 33. Turkey Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemangioma Revenue, (US$, Mn), 2017-2028
Figure 37. Akrimax Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cutting Edge Laser Technologies Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pierre Fabre Hemangioma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)